FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108941538> ?p ?o ?g. }

• W2108941538 endingPage "73" @default.
• W2108941538 startingPage "66" @default.
• W2108941538 abstract "Direct current cardioversion of persistent atrial fibrillation is one of the most widely used and effective treatments for the restoration of sinus rhythm, but may be hampered by a low success rate and a high percentage of early recurrence. Pre-treatment with amiodarone or a glucose-insulin-potassium solution could improve the efficacy of electrical cardioversion by reversing the partially depolarized diastolic potential of the subsidiary pacemakers in atrial fibrillation. In a controlled randomized study, we assessed the effectiveness of electrical cardioversion in patients with persistent atrial fibrillation after pre-treatment with amiodarone or potassium infusion and the efficacy of amiodarone in maintaining sinus rhythm after electrical cardioversion.Ninety-two patients with persistent atrial fibrillation (>2 weeks duration) were prospectively randomized into three matched groups: A (n=31, oral amiodarone 400 mg. day(-1)1 month before and 200 mg. day(-1)2 months after cardioversion), B (n=31, 180 mg. day(-1)oral diltiazem 1 month before and 2 months after cardioversion and 80 mmol potassium, 50 UI insulin in 500 ml 30% glucose solution 24 h before cardioversion) and C (n=30, control patients, 180 mg. day(-1)oral diltiazem 1 month before and 2 months after cardioversion). Before cardioversion all patients were under 4 weeks effective oral anticoagulant therapy (warfarin). Before electrical cardioversion, the rate of spontaneous conversion to sinus rhythm was higher in group A (25%) than groups B (6%) or C (3%) (P<0.005). Electrical cardioversion was more successful in group A (88%) than groups B (56%) or C (65%) (P<0.05), while the electrical thresholds for effective cardioversion were lower in group B than the other groups (P<0.05). Twenty-four hours after cardioversion, the early recurrence of atrial fibrillation was similar in the three groups (P=ns), while at 2 months the recurrence rate was lower in group A (32%) than groups B (56%) or C (52%) (P<0.01).Pre-treatment with low-dose oral amiodarone, compared with oral diltiazem or glucose-insulin-potassium treatments, induces a significantly high percentage of instances of spontaneous conversion, increases electrical cardioversion efficacy and reduces atrial fibrillation recurrence." @default.
• W2108941538 created "2016-06-24" @default.
• W2108941538 creator A5009499756 @default.
• W2108941538 creator A5051985100 @default.
• W2108941538 creator A5057717133 @default.
• W2108941538 creator A5073723279 @default.
• W2108941538 creator A5086153061 @default.
• W2108941538 date "2000-01-01" @default.
• W2108941538 modified "2023-10-12" @default.
• W2108941538 title "Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation" @default.
• W2108941538 cites W1841210729 @default.
• W2108941538 cites W1905187174 @default.
• W2108941538 cites W1964999753 @default.
• W2108941538 cites W1967121574 @default.
• W2108941538 cites W1971005887 @default.
• W2108941538 cites W1973215845 @default.
• W2108941538 cites W1974984582 @default.
• W2108941538 cites W1981070043 @default.
• W2108941538 cites W2006694009 @default.
• W2108941538 cites W2007731253 @default.
• W2108941538 cites W2008302908 @default.
• W2108941538 cites W2009414043 @default.
• W2108941538 cites W2010386758 @default.
• W2108941538 cites W2017179259 @default.
• W2108941538 cites W2024137059 @default.
• W2108941538 cites W2032227708 @default.
• W2108941538 cites W2042033085 @default.
• W2108941538 cites W2047185570 @default.
• W2108941538 cites W2050948686 @default.
• W2108941538 cites W2053623462 @default.
• W2108941538 cites W2056431470 @default.
• W2108941538 cites W2064953660 @default.
• W2108941538 cites W2070145752 @default.
• W2108941538 cites W2072959339 @default.
• W2108941538 cites W2074913627 @default.
• W2108941538 cites W2082510854 @default.
• W2108941538 cites W2091200104 @default.
• W2108941538 cites W2092642063 @default.
• W2108941538 cites W2094290398 @default.
• W2108941538 cites W2107287569 @default.
• W2108941538 cites W2110006610 @default.
• W2108941538 cites W2112058034 @default.
• W2108941538 cites W2119285476 @default.
• W2108941538 cites W2119602054 @default.
• W2108941538 cites W2136048987 @default.
• W2108941538 cites W2145539940 @default.
• W2108941538 cites W2151007673 @default.
• W2108941538 cites W2151184079 @default.
• W2108941538 cites W303812557 @default.
• W2108941538 doi "https://doi.org/10.1053/euhj.1999.1734" @default.
• W2108941538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10610746" @default.
• W2108941538 hasPublicationYear "2000" @default.
• W2108941538 type Work @default.
• W2108941538 sameAs 2108941538 @default.
• W2108941538 citedByCount "137" @default.
• W2108941538 countsByYear W21089415382012 @default.
• W2108941538 countsByYear W21089415382013 @default.
• W2108941538 countsByYear W21089415382014 @default.
• W2108941538 countsByYear W21089415382015 @default.
• W2108941538 countsByYear W21089415382016 @default.
• W2108941538 countsByYear W21089415382017 @default.
• W2108941538 countsByYear W21089415382018 @default.
• W2108941538 countsByYear W21089415382020 @default.
• W2108941538 countsByYear W21089415382021 @default.
• W2108941538 countsByYear W21089415382022 @default.
• W2108941538 countsByYear W21089415382023 @default.
• W2108941538 crossrefType "journal-article" @default.
• W2108941538 hasAuthorship W2108941538A5009499756 @default.
• W2108941538 hasAuthorship W2108941538A5051985100 @default.
• W2108941538 hasAuthorship W2108941538A5057717133 @default.
• W2108941538 hasAuthorship W2108941538A5073723279 @default.
• W2108941538 hasAuthorship W2108941538A5086153061 @default.
• W2108941538 hasBestOaLocation W21089415381 @default.
• W2108941538 hasConcept C126322002 @default.
• W2108941538 hasConcept C164705383 @default.
• W2108941538 hasConcept C2775914520 @default.
• W2108941538 hasConcept C2776741139 @default.
• W2108941538 hasConcept C2777289489 @default.
• W2108941538 hasConcept C2778094803 @default.
• W2108941538 hasConcept C2778131192 @default.
• W2108941538 hasConcept C2779161974 @default.
• W2108941538 hasConcept C2780074459 @default.
• W2108941538 hasConcept C42219234 @default.
• W2108941538 hasConcept C519063684 @default.
• W2108941538 hasConcept C71924100 @default.
• W2108941538 hasConceptScore W2108941538C126322002 @default.
• W2108941538 hasConceptScore W2108941538C164705383 @default.
• W2108941538 hasConceptScore W2108941538C2775914520 @default.
• W2108941538 hasConceptScore W2108941538C2776741139 @default.
• W2108941538 hasConceptScore W2108941538C2777289489 @default.
• W2108941538 hasConceptScore W2108941538C2778094803 @default.
• W2108941538 hasConceptScore W2108941538C2778131192 @default.
• W2108941538 hasConceptScore W2108941538C2779161974 @default.
• W2108941538 hasConceptScore W2108941538C2780074459 @default.
• W2108941538 hasConceptScore W2108941538C42219234 @default.
• W2108941538 hasConceptScore W2108941538C519063684 @default.
• W2108941538 hasConceptScore W2108941538C71924100 @default.
• W2108941538 hasIssue "1" @default.

• next